Bliv review

Bliv for moms: our verdict

⛔ FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. A no-video-visit intake, from $116/mo semaglutide and $199/mo tirzepatide. It runs about $116/mo — toward the affordable end of what we track.

We looked at Bliv the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Bliv actually costs

• Compounded semaglutide — Starting price: $116/mo
• Compounded tirzepatide — Starting price: $199/mo

That lands below the median ongoing price of about $177 across the providers we track for moms — a real cost advantage.

Bliv's price scales with your dose, so the number you start at is not the number you'll pay at maintenance. Ask what the highest dose costs before you commit.

That price covers the consult, the medication and shipping.

The medications Bliv prescribes

Bliv lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

Where it operates. Bliv publishes no state list, so confirm it serves yours before you pay anything.

Where Bliv fits — and where it doesn't — for moms

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Bliv is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.